share_log

久光製薬:HP-6050(経皮吸収型鎮静剤)の国内第2相臨床試験結果のお知らせ

Hisamitsu Pharmaceutical: Announcements of individual stocks: Announcement of results for the domestic Phase 2 clinical trial of HP-6050 (transdermal sedative).

JPX ·  Jul 1, 2024 14:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more